Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Avid Bioservices, Inc. (CDMO)
|
Add to portfolio |
|
|
|
| Price: |
$19.24
| | Metrics |
| OS: |
62.5
|
M
| |
63
|
% ROE
|
| Market cap: |
$1.2
|
B
| |
69
|
% ROIC
|
|
Net cash:
|
$59.9
|
M
| |
$0.96
|
per share
|
|
EV:
|
$1.14
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$10.6
|
M
| |
108.0
|
x EV/EBITDA
|
|
EBIT
|
$3.8
|
M
| |
297.9
|
x EV/EBIT
|
| EPS |
$1.65
| |
11.6
|
x P/E
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Apr-30-22 | Apr-30-21 | Apr-30-20 | Apr-30-19 | Apr-30-18 | Apr-30-17 | Apr-30-16 | Apr-30-15 |
| Revenues | 119.6 | 95.9 | 59.7 | 53.6 | 53.6 | 57.6 | 44.4 | 26.8 |
| Revenue growth | 24.8% | 60.6% | 11.4% | 0.0% | -7.0% | 29.9% | 65.6% | 19.6% |
| Cost of goods sold | 82.9 | 66.6 | 55.8 | 46.4 | 56.5 | 38.3 | 23.0 | 15.6 |
| Gross profit | 36.6 | 29.3 | 3.9 | 7.2 | -2.9 | 19.4 | 21.4 | 11.2 |
| Gross margin | 30.6% | 30.6% | 6.6% | 13.5% | -5.5% | 33.6% | 48.2% | 41.6% |
| Selling, general and administrative | 21.2 | 17.1 | 14.5 | 12.8 | 16.5 | 18.1 | 17.9 | 18.7 |
| Research and development | | | | | | | | 43.0 |
| EBIT | 15.4 | 12.2 | -10.9 | -5.6 | -20.6 | 1.3 | 3.5 | -50.5 |
| EBIT margin | 12.9% | 12.8% | -18.3% | -10.5% | -38.5% | 2.2% | 7.9% | -188.6% |
| Pre-tax income | 12.7 | 11.2 | -10.5 | -5.3 | -20.6 | 1.4 | 3.6 | -50.4 |
| Income taxes | -115.0 | 0.0 | 0.0 | -0.3 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | | 0.0% | 0.0% | 5.3% | 0.0% | 0.0% | 0.0% | 0.0% |
| Earnings from continuing ops | 127.7 | 3.3 | -15.2 | -9.7 | -25.2 | -3.2 | -0.9 | -54.1 |
| Earnings from discontinued ops | | | | 0.8 | -1.3 | -29.6 | -59.2 | |
| Net income | 127.7 | 3.3 | -15.2 | -8.9 | -26.5 | -32.8 | -60.1 | -54.1 |
| Net margin | 106.8% | 3.5% | -25.4% | -16.6% | -49.4% | -56.9% | -135.6% | -201.8% |
| |
| Diluted EPS | $1.81 | $0.06 | ($0.27) | ($0.17) | ($0.54) | ($0.09) | ($0.03) | ($2.07) |
| Shares outstanding (diluted) | 70.5 | 59.4 | 56.3 | 56.0 | 47.1 | 37.1 | 30.9 | 26.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|